BACKGROUND: Randomized intervention trials in which the community is the unit of randomization are increasingly being used to evaluate the impact of public health interventions. In the design of community randomized trials (CRT), the power of the study is likely to be affected by two issues: the matching or stratification of communities, and the number and size of the communities to be randomized. METHODS: Data from three East African community intervention trials, designed to evaluate the impact of interventions to reduce human immunodeficiency virus (HIV) incidence, are used to compare the efficiency of different trial designs. RESULTS: Compared with an unmatched design, stratification reduced the between-community variation in the Mwanza trial (from 0.51 to 0.24) and in the Masaka trial (from 0.38 to 0.28). The reduction was smaller in the Rakai trial where the selected communities were more homogeneous (from 0.15 to 0.11). For all trials, individual matching of communities produced estimates of between-community variation similar to those from the stratified designs. The linear association between HIV prevalence and incidence was strong in the Mwanza trial (correlation coefficient R = 0.83) and the Masaka trial (R = 0.83), but weak in the Rakai trial (R = 0.28). Unmatched study designs that use smaller communities tend to increase between-community variation, but reduce the design effect and improve study power. CONCLUSIONS: These empirical data suggest that selection of homogeneous communities, or stratification of communities prior to randomization, may improve the power of CRT.
BACKGROUND: Randomized intervention trials in which the community is the unit of randomization are increasingly being used to evaluate the impact of public health interventions. In the design of community randomized trials (CRT), the power of the study is likely to be affected by two issues: the matching or stratification of communities, and the number and size of the communities to be randomized. METHODS: Data from three East African community intervention trials, designed to evaluate the impact of interventions to reduce human immunodeficiency virus (HIV) incidence, are used to compare the efficiency of different trial designs. RESULTS: Compared with an unmatched design, stratification reduced the between-community variation in the Mwanza trial (from 0.51 to 0.24) and in the Masaka trial (from 0.38 to 0.28). The reduction was smaller in the Rakai trial where the selected communities were more homogeneous (from 0.15 to 0.11). For all trials, individual matching of communities produced estimates of between-community variation similar to those from the stratified designs. The linear association between HIV prevalence and incidence was strong in the Mwanza trial (correlation coefficient R = 0.83) and the Masaka trial (R = 0.83), but weak in the Rakai trial (R = 0.28). Unmatched study designs that use smaller communities tend to increase between-community variation, but reduce the design effect and improve study power. CONCLUSIONS: These empirical data suggest that selection of homogeneous communities, or stratification of communities prior to randomization, may improve the power of CRT.
Authors: Larry W Chang; Joseph Kagaayi; Hannah Arem; Gertrude Nakigozi; Victor Ssempijja; David Serwadda; Thomas C Quinn; Ronald H Gray; Robert C Bollinger; Steven J Reynolds Journal: AIDS Behav Date: 2011-11
Authors: Mary Jane Rotheram-Borus; Ingrid M le Roux; Mark Tomlinson; Nokwanele Mbewu; W Scott Comulada; Karl le Roux; Jacqueline Stewart; Mary J O'Connor; Mary Hartley; Kate Desmond; Erin Greco; Carol M Worthman; Faith Idemundia; Dallas Swendeman Journal: Prev Sci Date: 2011-12
Authors: Suzanne Maman; Tim Lane; Jacob Ntogwisangu; Precious Modiba; Heidi vanRooyen; Andrew Timbe; Surasing Visrutaratna; Katherine Fritz Journal: Field methods Date: 2009-11
Authors: Linda Richter; Mary Jane Rotheram-Borus; Alastair Van Heerden; Alan Stein; Mark Tomlinson; Jessica M Harwood; Tamsen Rochat; Heidi Van Rooyen; W Scott Comulada; Zihling Tang Journal: AIDS Behav Date: 2014-04
Authors: Larry W Chang; Joseph Kagaayi; Gertrude Nakigozi; Victor Ssempijja; Arnold H Packer; David Serwadda; Thomas C Quinn; Ronald H Gray; Robert C Bollinger; Steven J Reynolds Journal: PLoS One Date: 2010-06-02 Impact factor: 3.240
Authors: Jennifer A Wagman; Ronald H Gray; Jacquelyn C Campbell; Marie Thoma; Anthony Ndyanabo; Joseph Ssekasanvu; Fred Nalugoda; Joseph Kagaayi; Gertrude Nakigozi; David Serwadda; Heena Brahmbhatt Journal: Lancet Glob Health Date: 2014-11-28 Impact factor: 26.763
Authors: Joseph K B Matovu; Jim Todd; Rhoda K Wanyenze; Fred Wabwire-Mangen; David Serwadda Journal: Glob Health Action Date: 2015-06-08 Impact factor: 2.640